PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
38.72%
Positive revenue growth while JHX is negative. John Neff might see a notable competitive edge here.
380.04%
Positive gross profit growth while JHX is negative. John Neff would see a clear operational edge over the competitor.
2200.72%
Positive EBIT growth while JHX is negative. John Neff might see a substantial edge in operational management.
2200.72%
Positive operating income growth while JHX is negative. John Neff might view this as a competitive edge in operations.
272.22%
Positive net income growth while JHX is negative. John Neff might see a big relative performance advantage.
276.92%
Positive EPS growth while JHX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
276.92%
Positive diluted EPS growth while JHX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.23%
Share reduction more than 1.5x JHX's 3.51%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.12%
Reduced diluted shares while JHX is at 3.83%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
292.55%
10Y CAGR of 292.55% while JHX is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
88.75%
5Y CAGR of 88.75% while JHX is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
121.56%
3Y CAGR of 121.56% while JHX is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
516.49%
10Y net income/share CAGR of 516.49% while JHX is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
89.69%
Net income/share CAGR of 89.69% while JHX is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-23.58%
Negative 3Y CAGR while JHX is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while JHX invests at 16.22%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.